(Q44587073)
Statements
Synthesis and biological evaluation of metabolites of 2-n-butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), a potent antagonist of the A2A adenosine receptor for the treatment of Parkinson's disease (English)
Maria Antonietta Stasi
Teresa Riccioni
Franco Borsini
Giorgio Tarzia